9-127804349-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004957.6(FPGS):āc.203A>Cā(p.Gln68Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004957.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FPGS | NM_004957.6 | c.203A>C | p.Gln68Pro | missense_variant | 2/15 | ENST00000373247.7 | NP_004948.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FPGS | ENST00000373247.7 | c.203A>C | p.Gln68Pro | missense_variant | 2/15 | 1 | NM_004957.6 | ENSP00000362344 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251286Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135868
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.0000316 AC XY: 23AN XY: 727232
GnomAD4 genome AF: 0.000236 AC: 36AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.203A>C (p.Q68P) alteration is located in exon 2 (coding exon 2) of the FPGS gene. This alteration results from a A to C substitution at nucleotide position 203, causing the glutamine (Q) at amino acid position 68 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at